Recent news of an impending clinical cell transplantation trial in Parkinson's disease using parthenogenetic stem cells as a source of donor tissue have raised hopes in the patient community and sparked discussion in the research community. Based on discussions held by a global collaborative initiative on translation of stem cell therapy in Parkinson's disease, we have identified a set of key questions that we believe should be addressed ahead of every clinical stem cell-based transplantation trial in this disorder. In this article, we first provide a short history of cell therapy in Parkinson's disease and briefly describe the current state-of-art regarding human stem cell-derived dopamine neurons for use in any patient trial. With this ba...
Stem-cell-derived transplants may soon be a promising treatment option for Parkinson's disease. In p...
Current approaches to cell replacement therapy in Parkinson's disease are strongly focused on the do...
Cell-replacement therapies have long been an attractive prospect for treating Parkinson disease. How...
Recent news of an impending clinical cell transplantation trial in Parkinson's disease using parthen...
Recent news of an impending clinical cell transplantation trial in Parkinson’s disease using parthen...
Stem cell-based therapies for Parkinson's disease are moving into a new and exciting era, with sever...
Treating neurodegenerative diseases with cell transplantation has been within reach since the first ...
Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alz-heimer's dis...
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive accumulati...
Cell replacement therapy is a widely discussed novel concept of medical treatment. The increased kno...
Over the past three decades, significant progress has been made in the development of potential rege...
In Parkinson's disease (PD), the main pathology underlying the motor symptoms is a loss of nigrostri...
Parkinson's disease (PD) is the most common movement disorder. The neuropathology is characterized b...
Stem cell based therapies for Parkinson’s disease are moving into a new and exciting era, with sever...
Parkinson's disease (PD) patients display motor symptoms, e.g. tremor, rigidity and bradykinesia, la...
Stem-cell-derived transplants may soon be a promising treatment option for Parkinson's disease. In p...
Current approaches to cell replacement therapy in Parkinson's disease are strongly focused on the do...
Cell-replacement therapies have long been an attractive prospect for treating Parkinson disease. How...
Recent news of an impending clinical cell transplantation trial in Parkinson's disease using parthen...
Recent news of an impending clinical cell transplantation trial in Parkinson’s disease using parthen...
Stem cell-based therapies for Parkinson's disease are moving into a new and exciting era, with sever...
Treating neurodegenerative diseases with cell transplantation has been within reach since the first ...
Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alz-heimer's dis...
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive accumulati...
Cell replacement therapy is a widely discussed novel concept of medical treatment. The increased kno...
Over the past three decades, significant progress has been made in the development of potential rege...
In Parkinson's disease (PD), the main pathology underlying the motor symptoms is a loss of nigrostri...
Parkinson's disease (PD) is the most common movement disorder. The neuropathology is characterized b...
Stem cell based therapies for Parkinson’s disease are moving into a new and exciting era, with sever...
Parkinson's disease (PD) patients display motor symptoms, e.g. tremor, rigidity and bradykinesia, la...
Stem-cell-derived transplants may soon be a promising treatment option for Parkinson's disease. In p...
Current approaches to cell replacement therapy in Parkinson's disease are strongly focused on the do...
Cell-replacement therapies have long been an attractive prospect for treating Parkinson disease. How...